SCHEDULE OF BUSINESS INTERESTS INTO REPORTABLE SEGMENTS (Details) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Segment Reporting Information [Line Items] | ||||||||||
| Revenue | $ 2,400,311 | $ 2,550,046 | $ 8,919,312 | $ 7,501,535 | $ 9,889,433 | $ 17,122,520 | ||||
| Gross Profit | 1,401,991 | 1,281,041 | 3,908,608 | 3,505,743 | 4,745,965 | 5,707,322 | ||||
| Segment Assets | 4,689,261 | 5,514,101 | 4,689,261 | 5,514,101 | 5,766,164 | 9,792,702 | ||||
| Segment Profit/Loss | (528,742) | $ (1,112,261) | $ (965,836) | (1,301,748) | $ (2,578,276) | $ (651,519) | (2,606,839) | (4,531,543) | (5,315,883) | (2,536,051) |
| Cost of Sales | 5,010,704 | 3,995,792 | ||||||||
| Trxade, Inc.[Member] | ||||||||||
| Segment Reporting Information [Line Items] | ||||||||||
| Revenue | 4,001,670 | 3,653,269 | 4,924,015 | 5,546,746 | ||||||
| Gross Profit | 4,001,670 | 3,652,015 | 4,921,084 | 5,546,746 | ||||||
| Segment Assets | 1,853,474 | 1,487,657 | 1,853,474 | 1,487,657 | 2,273,330 | 2,076,934 | ||||
| Segment Profit/Loss | 1,320,138 | 1,511,809 | 1,977,938 | 3,309,128 | ||||||
| Cost of Sales | 1,254 | |||||||||
| Community Specialty Pharmacy, LLC [Member] | ||||||||||
| Segment Reporting Information [Line Items] | ||||||||||
| Revenue | 905,083 | 1,287,296 | 1,652,841 | 1,653,924 | ||||||
| Gross Profit | (114,387) | 123,470 | 156,785 | 107,771 | ||||||
| Segment Assets | 236,827 | (404,174) | 236,827 | (404,174) | (431,593) | (457,784) | ||||
| Segment Profit/Loss | (363,212) | (89,025) | (128,563) | (900,427) | ||||||
| Cost of Sales | 1,019,470 | 1,163,826 | ||||||||
| Integra Pharma, LLC [Member] | ||||||||||
| Segment Reporting Information [Line Items] | ||||||||||
| Revenue | 3,949,772 | 2,511,270 | 3,250,561 | 9,877,067 | ||||||
| Gross Profit | (41,462) | (319,104) | (393,582) | 8,374 | ||||||
| Segment Assets | 454,783 | 563,396 | 454,783 | 563,396 | 565,619 | 2,698,357 | ||||
| Segment Profit/Loss | (493,203) | (2,500,032) | (2,749,028) | (531,092) | ||||||
| Cost of Sales | 3,991,234 | 2,830,374 | ||||||||
| Other Segments [Member] | ||||||||||
| Segment Reporting Information [Line Items] | ||||||||||
| Revenue | 62,787 | 49,700 | 62,016 | 44,783 | ||||||
| Gross Profit | 62,787 | 49,362 | 61,678 | 44,431 | ||||||
| Segment Assets | $ 2,111,177 | $ 3,867,221 | 2,111,177 | 3,867,221 | 3,358,808 | 5,475,195 | ||||
| Segment Profit/Loss | (3,070,562) | (3,454,295) | $ (4,416,230) | $ (4,413,660) | ||||||
| Cost of Sales | $ 338 | |||||||||
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|